Christopher Hix joins Brady Corporation Board of Directors

Core Insights - Brady Corporation has appointed Christopher Hix to its Board of Directors effective May 24, 2024, bringing extensive experience in financial leadership and strategic growth [1][2]. Group 1: Christopher Hix's Background - Mr. Hix has a 39-year career in public companies across various global markets, including serving as CFO of Enovis Corporation from 2016 to 2022, where he led the transformation to medical technologies [2]. - He held the CFO position at OM Group, Inc. from 2012 until its acquisition in late 2015, and at Robbins & Myers from 2006 to 2011, during significant expansion [2]. - Hix has also spent 14 years in various roles at Roper Industries, contributing to its growth and transition to public ownership [2]. - He served on the Board of Directors of ESAB Corporation from 2021 to 2024, a company with $3 billion in revenue [2]. Group 2: Educational Background - Mr. Hix holds an MBA from St. Mary's College of California and a Bachelor of Science in Business Administration from the University of Southern California [3]. - He earned his public accounting certification early in his career [3]. Group 3: Strategic Vision for Brady - Hix emphasized Brady's commitment to profitable growth through innovation, R&D, technology investments, and strategic M&A to enhance shareholder value [4]. - The Chair of Brady's Board of Directors highlighted Hix's extensive financial and strategic experience as a key asset for accelerating growth [4]. - Brady's President and CEO noted that Hix's experience in leading high-technology global businesses and M&A will be invaluable for pursuing long-term growth opportunities [5]. Group 4: Company Overview - Brady Corporation is an international manufacturer and marketer of solutions that enhance safety, security, productivity, and performance, with a diverse product range including labels, signs, safety devices, and software [6]. - Founded in 1914, Brady serves various industries such as electronics, telecommunications, manufacturing, and medical, employing approximately 5,600 people as of July 31, 2023 [6]. - The company's fiscal 2023 sales were approximately $1.33 billion, and its stock trades on the New York Stock Exchange under the symbol BRC [6].